Ebiox is pleased to announce
that they have signed an agreement with Kanbeier Medical who are based in
Hangzhou, Zheijang Province with a focus on rebuilding the brand and sales into
the Chinese Healthcare Market.
Ebiox products are setting the standard for clinical excellence, and can be used anywhere where effective decontamination is a necessity for infection prevention and control.
Tuesday, 29 April 2014
Wednesday, 15 January 2014
Distribution Agreement with Dalian EBOS (China) Has Been Terminated
Due to actions taken by Dalian EBOS the distributor for Ebiox products in China we have no other course but to terminate the distribution agreement which we held with them.
It should be noted that no products or communications under the name EBOS or Ebos Medical Co Ltd have any connection or authorisation from Ebiox Limited.
It should be noted that no products or communications under the name EBOS or Ebos Medical Co Ltd have any connection or authorisation from Ebiox Limited.
Tuesday, 10 December 2013
Ebiox Completes a Distribution Agreement for Livinguard
With a number of key areas now identified as vehicles for cross infection, the objective of Ebiox as a provider of Infection Prevention and Control Products is to offer a product portfolio which will give the tools to combat infection in these identified areas.
It is well publicised that hands, the environment and surgical instruments are factors in Healthcare Acquired Infections for which Ebiox has a focussed range of products targeting these areas.
Studies show that Healthcare Workers clothing, patient attire and soft fabrics such as curtains are also vehicles for cross infection. So to try and break this chain Ebiox is now working with a company Livinguard who manufactures a patented range of medical clothing and items.
With the use of multiple coating applications Ebiox can over a range of clothing which is;
Anti-microbial for up to 75 washes
Hydrophobic which prevents penetration of fluids
Hydrophilic for wearers comfort. This is enhanced by the use of
high quality non linting Poly/Cotton fabric
Stain resistent for easy laundering
Livinguard kills micro-organisms by a "mechnical" action rather than chemical. The textile is coated with billions of nano sized polymeric knives, spaced in a way that when bacteria for example hits the textile they are physically pierced, killing them.
Due to this being a mechanical action and not chemical there is no risk of resistance.
The textiles have gone through many tests, and has recently passed the EN13795, the European Standard for Surgical Drapes and Gowns for use in the Operating Theatre.
Ebiox believes this is an excellent addition to their portfolio, meeting their objective of providing products which will help close down many of the avenues of cross infection.
It is well publicised that hands, the environment and surgical instruments are factors in Healthcare Acquired Infections for which Ebiox has a focussed range of products targeting these areas.
Studies show that Healthcare Workers clothing, patient attire and soft fabrics such as curtains are also vehicles for cross infection. So to try and break this chain Ebiox is now working with a company Livinguard who manufactures a patented range of medical clothing and items.
With the use of multiple coating applications Ebiox can over a range of clothing which is;
Anti-microbial for up to 75 washes
Hydrophobic which prevents penetration of fluids
Hydrophilic for wearers comfort. This is enhanced by the use of
high quality non linting Poly/Cotton fabric
Stain resistent for easy laundering
Livinguard kills micro-organisms by a "mechnical" action rather than chemical. The textile is coated with billions of nano sized polymeric knives, spaced in a way that when bacteria for example hits the textile they are physically pierced, killing them.
Due to this being a mechanical action and not chemical there is no risk of resistance.
The textiles have gone through many tests, and has recently passed the EN13795, the European Standard for Surgical Drapes and Gowns for use in the Operating Theatre.
Ebiox believes this is an excellent addition to their portfolio, meeting their objective of providing products which will help close down many of the avenues of cross infection.
Ebiox Signs an Exclusive Distribution Agreement for the Kingdom of Saudi Arabia
It is with great pleasure to announce that Ebiox has signed and exclusive agreement for the distribution of their Infection Prevention and Control product portfolio for the Kingdom of Saudi Arabia.
We are are very confident that our distributor partner there, ScienPharma will gain success in what is potentially an excellent opportunity for both companies.
We are are very confident that our distributor partner there, ScienPharma will gain success in what is potentially an excellent opportunity for both companies.
Thursday, 14 November 2013
Customer Services Update
We continually review the demands on the support we give our
Distributor Partners and Direct Customers. We believe that as the business has
grown this year there was a need to re-structure and grow the support within
the Customer Services Team.
We are delighted to bring on board Palina Meesala who will
be focussing on the “day to day” aspects of customer support. Her email is palina.meesala@ebiox.co.uk and
direct phone line will be +44 (0)1925 856271.
Wendy Bradford will be supporting key projects and key
Distributor Partner accounts as well as providing support to the Head Office
team as required. Her email remains wendy.bradford@ebiox.co.uk
we will let you have her direct telephone contact number once in place.
Can I also ask that all email orders be now placed using the
following address sales@ebiox.co.uk
We wish Palina and Wendy much success in their new roles and
this additional support will be seen as a positive step forward in the support
we can offer you.
Saturday, 24 August 2013
Ebiox Enters the Turkish Healthcare Market
It is with great pleasure for Ebiox to announce they have established a Distributor Partnership with Saniturk who have extensive experience in the Instrument Cleaning and Infection Control sectors with the Turkish Healthcare providers.
Ebiox looks forward to establishing a strong business base in this very important market.
Ebiox looks forward to establishing a strong business base in this very important market.
Thursday, 18 July 2013
Ebiox Strengthens Their Distributor Partner Network
Ebiox are pleased to announce the addition of
three new Distributor Partners.
ScienPharma - Kingdom of Saudi Arabia
Saniturk - Turkey
Greenpol Ltd - Poland
The addition of these three high quality
partners strengthens Ebiox's Distribution network into these key market areas.
Subscribe to:
Posts (Atom)